Endosymbiosis has driven major molecular and cellular innovations. Plasmodium spp. parasites that cause malaria contain an essential, non-photosynthetic plastid, the apicoplast, which originated from a secondary (eukaryote-eukaryote) endosymbiosis. To discover organellar pathways with evolutionary and biomedical significance, we performed a mutagenesis screen for essential genes required for apicoplast biogenesis in P. falciparum. Apicoplast-minus mutants were isolated using a chemical rescue that permits conditional disruption of the apicoplast and a new fluorescent reporter for organelle loss. Five candidate genes were validated (out of 12 identified), including a TIM-barrel protein that likely derived from a core metabolic enzyme but evolved a new activity. Our results demonstrate the first forward genetic screen to assign essential cellular functions to unannotated P. falciparum genes. A putative TIM-barrel enzyme and other newly-identified apicoplast biogenesis proteins open opportunities to discover new mechanisms of organelle biogenesis, molecular evolution underlying eukaryotic diversity, and drug targets against multiple parasitic diseases.
Introduction
Plasmodium spp. which cause malaria and related apicomplexan parasites are important human and veterinary pathogens. These disease-causing protozoa are highly divergent from wellstudied model organisms that are the textbook examples of eukaryotic biology, such that parasite biology often reveals striking eukaryotic innovations. The apicoplast, a nonphotosynthetic plastid found in apicomplexa, is one such "invention" (Kohler et al., 1997; McFadden et al., 1996) . These intracellular parasites evolved from photosynthetic algae that acquired their plastids through secondary endosymbiosis (van Dooren and Striepen, 2013) . During secondary endosymbiosis, a chloroplast-containing alga, itself the product of primary endosymbiosis, was taken up by another eukaryote to form a secondary plastid (Gibbs, 1978) . Despite the loss of photosynthesis in apicomplexans, the apicoplast contains several prokaryotic metabolic pathways, is essential for parasite replication during human infection, and is a target of antiparasitic drugs (Dahl and Rosenthal, 2007; Fichera and Roos, 1997; Ralph et al., 2004; Sheiner et al., 2013) .
There are many traces of the apicoplast's quirky evolution in its present-day cell biology, in particular the pathways for its biogenesis. Like other endosymbiotic organelles, the single apicoplast cannot be formed de novo and must be inherited by its growth, division, and segregation into daughter cells. The few molecular details we have about apicoplast biogenesis hint at the major innovations that have occurred in the process of adopting and retaining this secondary plastid. The apicoplast is bound by four membranes acquired through successive endosymbioses, such that apicoplast proteins transit through the ER and use a symbiont-derived ERAD-like machinery (SELMA) to cross the two new outer membranes (Agrawal et al., 2009) . Curiously, autophagy-related protein 8 (Atg8), a highly-conserved eukaryotic protein and key marker of autophagosomes, localizes to the apicoplast and is required for its inheritance in Plasmodium and related apicomplexan parasite Toxoplasma gondii (Kitamura et al., 2012; Leveque et al., 2015; Walczak et al., 2018) . While SELMA and PfAtg8 are clear examples of molecular evolution in action, other novel or repurposed proteins required for apicoplast biogenesis remain undiscovered.
So far, new apicoplast biogenesis proteins have primarily been discovered through candidate approaches. SELMA was first identified as homologs of the ER-associated degradation (ERAD) machinery encoded in the nucleomorph, the remnant nucleus of the eukaryotic symbiont found in some algal secondary plastids (Sommer et al., 2007) . Nuclear-encoded versions of SELMA containing apicoplast targeting sequences were then detected in the genomes of apicomplexan parasites (which lack a nucleomorph) (Spork et al., 2009 ). Since the apicoplast proteome is enriched in biogenesis functions, several apicoplast-targeted proteins of unknown function have also been shown to be required for its biogenesis (Sheiner et al., 2011) (unpublished data). ATG8's novel apicoplast function was discovered serendipitously by its unexpected localization on the apicoplast instead of autophagosomes (Kitamura et al., 2012) . Though candidate approaches have yielded new molecular insight (Biddau et al., 2018; Fellows et al., 2017; Sheiner et al., 2015) , in general they are indirect and may bias against novel pathways.
In blood-stage P. falciparum, a remarkable method to chemically rescue parasites that have lost the apicoplast has paved the way for functional screens (Gisselberg et al., 2018; Wu et al., 2015; Yeh and DeRisi, 2011) . Incredibly, addition of isopentenyl diphosphate (IPP) to the growth media is sufficient to reverse growth inhibition caused by apicoplast loss, since it is the only essential metabolic product of the apicoplast in the blood stage. Taking advantage of the apicoplast chemical rescue, we recently took the first unbiased approach to discover a new apicoplast biogenesis protein (Amberg-Johnson et al., 2017) . We first screened for small molecule inhibitors that specifically disrupt apicoplast biogenesis in P. falciparum. Subsequent target identification led us to a membrane metalloprotease, PfFtsH1, with an unexpected role in apicoplast biogenesis. This chemical genetic screen has the advantage of unbiased sampling of druggable targets in apicoplast biogenesis pathways. Unfortunately, it lacks throughput given the painstaking process of mapping inhibitors to their molecular targets.
Forward genetic screens are powerful approaches to uncover novel cellular pathways, such as those required for apicoplast biogenesis. Recently, genome-scale deletion screens performed in several apicomplexan parasites have uncovered a plethora of essential genes of unknown function (Bushell et al., 2017; Sidik et al., 2016; Zhang et al., 2018) . Several challenges impede large-scale functional analysis of these essential genes. First, targeted gene modifications are still slow and labor-intensive in P. falciparum, the deadliest of the human malaria species and the only Plasmodium spp. that can be cultured in vitro (Schuster, 2002; Trager and Jensen, 1976) . Second, efficient methods for generating conditional mutants, such as RNAi or CRISPRi systems, are lacking in all apicomplexan organisms (de Koning-Ward et al., 2015) . Finally, high-throughput, single-cell phenotyping for important functions need to be developed (Matz and Kooij, 2015) . Overcoming these significant limitations, we designed a forward genetic screen using chemical mutagenesis, apicoplast chemical rescue, and a fluorescent reporter for apicoplast loss to identify essential apicoplast biogenesis genes in bloodstage P. falciparum. The screen identified known and novel genes required for apicoplast biogenesis and is the first forward genetic screen for essential pathways in P. falciparum.
Results

A conditional fluorescent reporter enables single-cell phenotyping of apicoplast loss in P. falciparum
To isolate rare P. falciparum mutants that have lost their apicoplast due to biogenesis defects, we set out to design a live-cell reporter for apicoplast loss. The apicoplast contains a prokaryotic caseinolytic protease (Clp) system composed of a chaperone ClpC that recognizes and unfolds substrates and a protease ClpP that degrades the recognized substrates (El Bakkouri et al., 2010; Florentin et al., 2017; Rathore et al., 2010) . We hypothesized that (1) in the presence of a functional apicoplast, ClpCP could be co-opted to degrade and turn 'off' a fluorescent reporter, whereas (2) loss of the apicoplast would result in loss of ClpCP activity and therefore turn 'on' the reporter ( Figure 1A ).
Clp substrates are typically recognized by unstructured degron sequences, the best studied of which is a ssrA peptide appended to the C-terminus of translationally-stalled proteins (Gottesman et al., 1998; Keiler et al., 1996) . However, the substrate specificity of the apicoplast ClpCP system has yet to be defined. Reasoning that PfClpCP homolog might recognize similar degrons as bacterial or algal Clp systems, we tested two degrons recognized by E. coli ClpXP, EcssrA and X7, and the predicted ssrA peptide in the red alga Cyanidium caldarium, CcssrA (Table S1 ) (Flynn et al., 2001; Hoskins and Wickner, 2006; Hudson and Williams, 2015) . To assess their functionality in P. falciparum, the C-terminus of an apicoplast-targeted GFP (ACPL-GFP) was modified with each of the degrons ( Figure 1B) . A cytosolic mCherry marker was also expressed on the same promoter as ACPL-GFP via a T2A 'skip' peptide to normalize apicoplast GFP levels to stage-specific promoter expression (Wagner et al., 2013) . Each construct was then integrated into an ectopic attB locus in Dd2 attB parasites to generate the reporter strains (Nkrumah et al., 2006) .
For each reporter strain, the ratio of GFP:mCherry fluorescence (as detected by flow cytometry) was assessed in untreated parasites containing an intact apicoplast, designated apicoplast(+), and in parasites treated with actinonin (which causes apicoplast loss via inhibition of PfFtsH1) and rescued with IPP rendering them apicoplast (-) . In the absence of a degron, the GFP:mCherry ratio decreased modestly in apicoplast(-) parasites compared to apicoplast(+) ( Figure 1C and S1A). Though GFP was present in both populations, live fluorescence microscopy confirmed its localization to a branched structure characteristic of the apicoplast in apicoplast(+) parasites and to dispersed punctae as previously reported in apicoplast(-) parasites ( Figure S1B ) (Yeh and DeRisi, 2011) . Addition of each of the 3 degrons to the C-terminus of ACPL-GFP caused a 60-84% decrease in the GFP:mCherry ratio in apicoplast(+) parasites, consistent with specific degradation of GFP ( Figure 1C ). In ACPL-GFP-EcssrA and ACPL-GFP-CcssrA populations, the GFP:mCherry ratio recovered to 88% and 44% relative to the ACPL-GFP population in apicoplast(-) parasites, respectively ( Figure 1C , 1E, and S1C). Unexpectedly, ACPL-GFP-X7 populations showed further reduction of GFP:mCherry in apicoplast(-) parasites ( Figure 1C and S1C). Notably, cytoplasmic mCherry levels were similar between apicoplast(+) and apicoplast(-) parasites in all reporter strains, suggesting that the differences in GFP levels were not due to altered expression levels (Figures S1D). Of the 3 degrons tested, both the EcssrA and CcssrA peptide caused apicoplast-specific GFP degradation as designed.
We further characterized ACPL-GFP-EcssrA, since the greatest recovery of GFP fluorescence following apicoplast loss was observed with this reporter ( Figure 1C ). Consistent with degradation of GFP in the apicoplast dependent on EcssrA peptide, ACPL-GFP-EcssrA protein was only detected in apicoplast(-) parasites while unmodified ACPL-GFP was detected in both apicoplast(+) and (-) parasites ( Figure 1D ). Of note, cleavage of the apicoplast-targeting ACPL sequence does not occur in apicoplast(-) parasites, resulting in a ACPL-GFP protein of higher molecular weight compared to apicoplast(+) parasites (Yeh and DeRisi, 2011) . Flow cytometry and live fluorescence microscopy confirmed that apicoplast(+) parasites displayed only cytosolic mCherry fluorescence, while apicoplast(-) parasites displayed both cytosolic mCherry and dispersed, punctate GFP fluorescence ( Figure 1E and 1F). Taken together, these results demonstrate that ACPL-GFP-EcssrA serves as a specific reporter for apicoplast loss in P. falciparum.
A phenotypic screen isolates a collection of apicoplast(-) mutant clones
Next we used the ACPL-GFP-EcssrA reporter strain to perform a phenotypic screen for apicoplast(-) mutants (Figure 2A ). Ring-stage parasites were mutagenized with the alkylating agents ethyl methanesulfonate (EMS) or N-ethyl-N-nitrosourea (ENU) to generate a diverse population of parasites, some of which harbor mutations in apicoplast biogenesis genes rendering them apicoplast (-) . To rescue the lethality of apicoplast loss, mutagenized parasites were supplemented with 200 µM IPP in the growth media. A control group of non-mutagenized parasites was also cultured with IPP to assess whether apicoplast(-) mutants naturally occurred over time in the absence of selective pressure to maintain the organelle.
After two replication cycles to allow for initial apicoplast loss, mCherry-expressing parasites displaying GFP fluorescence > ~70% percentile were isolated by fluorescence-activated cell sorting (FACS). Selected mCherry(+) and GFP(+) parasites were then allowed to propagate to a detectable parasitemia before being subjected to a another round of FACS. In one exemplary ENU-mutagenized population, a distinct population of GFP-positive parasites began to emerge after just two rounds of FACS ( Figure 2B ). Other populations showed enrichment beginning after three rounds of FACS. No significant enrichment of GFP signal was observed when parasites were (1) grown with IPP over time without FACS or (2) grown without IPP and subjected to FACS, suggesting that we specifically enriched for apicoplast(-) mutants. Parasites from the final enriched apicoplast(-) populations were individually sorted to generate apicoplast(-) clones derived from single parasites. Each clonal population was then re-checked for IPP-dependent growth and GFP fluorescence.
Whole-genome sequencing identifies 12 candidate genes required for apicoplast biogenesis
To determine the genetic basis of apicoplast loss, we sequenced the genomes of 51 apicoplast(-) clones (mutagenized = 40, non-mutagenized = 11) and three parent populations. Sequenced reads were mapped to the genome of Plasmodium falciparum 3D7 (version 35) with an average read depth of 26 for all samples. Notably, while the apicoplast genome was sequenced at an average depth of 16 reads in the parent populations, it was only detected with an average of 0.02 reads in apicoplast(-) clones ( Figure 2C ). Since the organellar genome is a marker for the apicoplast, the absence of the apicoplast genome confirmed the loss of the apicoplast in the sequenced clones (Amberg-Johnson et al., 2017; Yeh and DeRisi, 2011) .
We next performed single nucleotide variant (SNV) analysis. A raw variant list was generated for each sample by comparison to the reference 3D7 genome and included SNVs found in parent populations at ≥5% allele frequency (minimum one read) and in apicoplast(-) clones at ≥90% (minimum 5 reads). Any SNV identified in apicoplast (-) clones that was also identified in any of the three parent populations was removed. We also filtered out SNVs detected in non-coding regions or resulting in synonymous amino acid changes in coding regions. Finally, SNVs identified in hypervariable regions of the genome (including the rifin, stevor and EMP gene families) and/or previously annotated in the PlasmoDB single nucleotide polymorphism (SNP) database were excluded. After these filtering steps, 23 apicoplast(-) clones had at least one but no more than three SNVs that differed from the parent populations ( Figure  2D ; Table S2 ).
Since genes required for apicoplast biogenesis ought to be essential, we used essentiality data from literature or whole-genome deletion screens performed in blood-stage P. falciparum and P. berghei to prioritize gene candidates (Bushell et al., 2017; Zhang et al., 2018) . Of 18 unique SNVs identified, 12 were in genes categorized as "essential" in blood-stage P. falciparum and/or P. berghei (Table 1 and Table S2 ). Although PfFtsH1 (Pf3D7_1239700) is categorized as "dispensable" in the P. falciparum deletion screen, it has been shown experimentally to be essential (Zhang et al., 2018) . Overall, a mutation in one of these 12 essential gene candidates was identified in each of the 23 apicoplast(-) clones, consistent with the mutation causing apicoplast loss. Potentially disruptive mutations included a I437S variant in the known apicoplast biogenesis protein (PfFtsH1), truncation of autophagy-related protein 7 (PfAtg7) likely required for a cytoplasmic pathway for apicoplast biogenesis, and truncations of three proteins of unknown function (Pf3D7_0518100, Pf3D7_1305100, Pf3D7_1363700) ( Table 1) . The remaining candidates contained point mutations and had no known prior function in apicoplast biogenesis or localization to the organelle.
The Ile437Ser variant causes loss of PfFtsH1 activity in vitro
PfFtsH1 is an apicoplast membrane metalloprotease that was previously identified in a chemical genetic screen as the target of actinonin, an inhibitor that disrupts apicoplast biogenesis. Subsequent knockdown of PfFtsH1demonstrated that it is required for apicoplast biogenesis (Amberg-Johnson et al., 2017) . We hypothesized that the I437S variant identified in our screen disrupted PfFtsH1 function, leading to apicoplast loss. PfFtsH1 contains both an ATPase and peptidase domain. To test the effect of I437S on enzyme activity, we compared the activity of I437S with that of wild-type (WT) enzyme, an ATPase-inactive E249Q variant, and a peptidase-inactive D493A variant ( Figure 3A ). All enzymes were purified without the transmembrane domain as previously described (Amberg-Johnson et al., 2017) .
We first measured peptidase activity on a fluorescent casein substrate. Neither the I437S nor D493A variant had detectable peptidase activity, whereas WT enzyme turned over substrate at 0.4 min -1 ( Figure 3B ). As expected, WT and E249Q showed robust ATP-dependent proteolytic activity ( Figure 3B) . Similarly, the I437S and E249Q variants no detectable ATP hydrolysis activity, in contrast to both WT and the D493A variant ( Figure 3C ). Taken together, these results validate the identified missense mutation leading to expression of inactive PfFtsH1 I437S variant as causative for apicoplast loss.
PfAtg7, a member of the Atg8 conjugation pathway, is a cytoplasmic protein required for apicoplast biogenesis
Though non-apicoplast proteins are expected to play a role in apicoplast biogenesis, all apicoplast biogenesis proteins validated so far have localized to the apicoplast since this criteria is most often used to select candidates. A significant advantage of our forward genetic screen is that it can uncover non-apicoplast pathways required for apicoplast biogenesis, which are biased against by other approaches. A cytoplasmic protein strongly identified in our screen was PfAtg7 (Pf3D7_1126100), which contained a nonsense mutation causing a protein truncation at position Q719. The premature stop codon was upstream of the E1-like activating domain, consistent with PfAtg7 loss-of-function ( Figure 4A ). In yeast and mammalian cells, Atg7 is required for conjugation of autophagy-related protein 8 (Atg8) to the autophagosome membrane (Ichimura et al., 2000) . PfAtg7 has not specifically been implicated in apicoplast biogenesis; however, PfAtg8 has been shown to localize to the apicoplast membrane and be required for apicoplast biogenesis. In analogy with its role in autophagy, PfAtg7 is likely required for conjugating PfAtg8 to the apicoplast membrane. Therefore we suspected the loss-of-function mutant we identified caused apicoplast loss via loss of membrane-conjugated PfAtg8 (Walczak et al., 2018) .
To confirm PfAtg7's role in apicoplast biogenesis, we generated a P. falciparum strain in which it is conditionally expressed. The endogenous PfAtg7 locus in a NF54 pCRISPR strain was modified with a C-terminal triple HA tag and a 3'UTR RNA aptamer sequence that binds a TetR/DOZI repressor to generate PfAtg7-TetR/DOZI Wagner et al., 2014) . In the presence of anhydrotetracycline (ATc), the 3'UTR aptamer is unbound and PfAtg7-3xHA protein was detectable, albeit at low levels consistent with its low expression in published transcriptome data (PlasmoDB.org) ( Figure S2A and 4F) . Removal of ATc causes binding of the TetR/DOZI repressor, which resulted in undetectable PfAtg7 protein levels by western blot within one replication cycle ( Figure S2A and 4F ). Parasitemia also decreased over the course of several replication cycles, consistent with a previous study showing that PfAtg7 is essential ( Figure 4B ) (Walker et al., 2013) .
We tested whether the requirement for PfAtg7 was due to its role in apicoplast biogenesis. Growth inhibition caused by PfAtg7 knockdown was partially rescued by addition of IPP ( Figure 4B ). Furthermore, in -ATc/+IPP parasites, the apicoplast marker acyl-carrier protein (ACP) mislocalized from a discrete organellar localization to multiple cytoplasmic puncta, a hallmark of apicoplast loss ( Figure 4C ) (Yeh and DeRisi, 2011) . Loss of transit peptide cleavage of the apicoplast protein ClpP also confirmed apicoplast loss, since mislocalized apicoplast proteins do not undergo removal of their targeting sequences ( Figure 4D) (Gisselberg et al., 2013) (unpublished data). Interestingly, IPP rescue of PfAtg7 knockdown parasites was incomplete, raising the possibility that PfAtg7 is also required for a non-apicoplast function. Alternatively, PfAtg7 knockdown may cause stalling of apicoplast morphologic development leading to general cellular toxicity that cannot be fully rescued with IPP until apicoplast loss is complete. To test these models, instead of PfAtg7 knockdown followed by apicoplast loss, we first induced apicoplast loss with actinonin and then assessed the effects of PfAtg7 knockdown. PfAtg7 knockdown in apicoplast(-) parasites did not cause any additional growth defect and was fully rescued by IPP, suggesting that the partial rescue observed in apicoplast(+) parasites was due to the order of disruption ( Figure S3 ). These results confirmed that PfAtg7 is required for apicoplast biogenesis and likely is its only essential function.
Finally, to determine whether PfAtg7's role in apicoplast biogenesis was via PfAtg8 membrane conjugation, we transfected PfAtg7-TetR/DOZI with a transgene encoding GFP-PfAtg8. In this strain, GFP-PfAtg8 primarily localized to a branched structure in schizonts, consistent with its previously described apicoplast localization ( Figure 4E ) (Kitamura et al., 2012; Tomlins et al., 2013) . Upon PfAtg7 knockdown, GFP-PfAtg8 localization to this discrete structure was lost and accumulation in the cytoplasm was observed within a single replication cycle prior to apicoplast loss ( Figure 4E ). Membrane fractionation also showed an increased proportion of soluble GFP-PfAtg8, while PfAtg7 remained solely in the soluble fraction as expected for a cytoplasmic protein ( Figure 4F) . These results suggest that, like yeast and mammalian Atg7 homologs, PfAtg7 has a conserved function in conjugating Atg8 to lipids. Altogether, PfAtg7 stood out as a cytoplasmic protein required for apicoplast biogenesis identified in our screen.
Forward genetics identifies three "conserved Plasmodium proteins of unknown function" required for apicoplast biogenesis
The real power of forward genetics is the ability to uncover novel pathways without any a priori knowledge. Therefore we next turned our attention to the nearly 50% of the Plasmodium genome annotated as "conserved Plasmodium protein, unknown function." Three candidate genes (Pf3D7_0518100, Pf3D7_1305100, Pf3D7_1363700) encoding proteins of unknown function were identified in our screen. Incidentally, all were also identified in a proteomic dataset of apicoplast proteins (unpublished data). Each candidate harbored nonsense mutations that caused protein truncation. The position of the premature stop codon near the 5' end (Pf3D7_0518100, Pf3D7_1305100) or in the middle (Pf3D7_1363700) of the genes suggested that these were loss-of-function mutations ( Figure 5A ).
Therefore we assessed whether knockdown of these genes disrupted apicoplast biogenesis. Similar to the experiments performed to validate PfAtg7, ATc-regulated knockdown strains for each of the candidate genes were generated. Upon ATc removal, protein levels for each gene decreased within 24 hours as detected by western blot (Figure S2B -D). Significant growth inhibition was also observed for all candidate genes tested, with varying kinetics of growth inhibition observed for each candidate (Figure 5B , E, and H). Of note, the gene essentiality demonstrated here for Pf3D7_1305100 and Pf3D7_1363700 confirmed wholegenome essentiality data reported in P. berghei and/or P. falciparum. However, the essentiality of Pf3D7_0518100 did not agree with its "dispensable" annotation in the P. falciparum dataset. IPP supplementation reversed growth inhibition for all the candidates, demonstrating that their essentiality was due to an apicoplast-specific function (Figure 5B , E, and H). Finally, mislocalization of ACP and loss of transit peptide cleavage of ClpP confirmed apicoplast loss for all candidates ( Figure 5C -D, F-G, I-J). As these genes have so far lacked any functional annotation and given their shared knockdown phenotype, we designated them "apicoplast-minus, IPP-rescued" (amr) genes: amr1 (Pf3D7_1363700), amr2 (Pf3D7_0518100), and amr3 (Pf3D7_1305100). Taken together, we successfully identified three novel proteins of unknown function required for apicoplast biogenesis, prioritizing these amr genes for functional studies.
Sequence analysis of AMR1 homologs suggests gene duplication followed by evolution of a new function in apicoplast biogenesis
To set up future functional studies, we noted that PfAMR1 contained a TIM-barrel domain with closest homology to indole-3-glycerol phosphate synthase (IGPS), a highlyconserved enzyme in the tryptophan (trp) biosynthesis pathway (Imanian and Keeling, 2014; Jiroutova et al., 2007; Nagano et al., 2002) . This was surprising because Plasmodium and the related apicomplexan parasite Toxoplasma are trp auxotrophs (Liu et al., 2006; Pfefferkorn, 1984; Sibley et al., 1994) . Indeed, analysis of >30 apicomplexan genomes did not detect any of the other six trp biosynthetic enzymes, except the terminal enzyme trpB which was horizontally transferred into Cryptosporidium spp. (Huang et al., 2004) . Therefore we suspected that PfAMR1 may have a function unrelated to trp biosynthesis.
To test the conservation of active site residues, we aligned the sequences of several known IGPSs with IGPS homologs identified from P. falciparum, T. gondii, and V. brassicaformis ( Figure S4) (Jones, 1999; Pei et al., 2008; Slabinski et al., 2007) . V. brassicaformis, a member of the Chromerids, is the closest free-living, photosynthetic relative to apicomplexan parasites. It contains a secondary plastid with the same origin as the apicoplast, but as a free-living algae (Moore et al., 2008) , is also expected to have intact trp biosynthesis. Known catalytic and substrate binding residues based on enzyme structure-function studies performed in bacteria were first identified (Hennig et al., 2002) . For known IGPSs and one of the V. brassicaformis IGPS homologs (Vbra_4894), the key catalytic and substrate binding residues were all conserved, despite the vast evolutionary distance between bacteria, metazoans, and Chromerids/apicomplexans ( Figure 6A ). However, in PfAMR1 and the other two V. brassicaformis homologs, key functional residues were not conserved. Based on the conservation of functional residues, we separated these sequences into 2 groups: "canonical IGPS" sequences that have been shown or are likely to encode for IGPS activity and "IGPS-like" sequences (e.g. PfAMR1) which we suggest have functionally diverged.
We next looked at the pattern of canonical IGPS versus IGPS-like proteins through two biological transitions: loss of trp biosynthesis (Vitrella vs Plasmodium spp.) and loss of the apicoplast (Plasmodium vs Cryptosporidium spp.) ( Figure 6B ). As expected for a role in trp biosynthesis, canonical IGPS proteins were retained until the emergence of parasitism. In addition, genes encoding the remaining set of enzymes for trp biosynthesis were identified in the V. brassicaformis genome (Woo et al., 2015) . Unlike canonical IGPSs however, IGPS-like proteins were retained in parasites that have lost trp biosynthesis. Instead, loss of IGPS-like proteins is associated only with loss of the apicoplast in Cryptosporidium spp. This pattern of acquisition and loss of IGPS-like proteins suggests an apicoplast-specific function separate from trp biosynthesis.
Finally, we performed functional complementation to test the biochemical activity of canonical IGPS and IGPS-like genes from V. brassicaformis and P. falciparum. An E. coli strain (trpC9800) containing an inactivating mutation in trpC, the E. coli IGPS homolog, was grown on minimal agar (M9) (Yanofsky et al., 1971) . As expected, trpC9800 was dependent on trp supplementation for growth ( Figure 6C) . Complementation with the Vbra_4894 homolog also restored trpC9800 growth on M9, comparable to that of an E. coli strain with intact tryptophan biosynthesis, suggesting Vbra_4894 is an IGPS protein ( Figure 6D) . In contrast, neither PfAMR1 nor any of the IGPS-like genes were able to functionally replace trpC, supporting an alternative biochemical function.
Discussion
Apicoplast biogenesis provides a fascinating window into molecular evolution, including examples of proteins that have been reused (e.g. TIC/TOC complexes) (Kalanon et al., 2009; Sheiner et al., 2015; van Dooren et al., 2008) , repurposed (e.g. Atg8, SELMA) (Spork et al., 2009; Walczak et al., 2018) , or newly invented in the process of serial endosymbioses. Overcoming significant technical challenges in the Plasmodium experimental system, we designed a forward genetic screen to identify essential apicoplast biogenesis pathways. This singular screen opens up opportunities to discover evolutionary innovations obscured by candidate-based approaches, including cytoplasmic pathways and genes lacking any functional annotations. In addition to confirming the role of PfFtsH1 in apicoplast biogenesis and identification of PfAtg8 conjugation machinery, we identified several proteins of unknown function required for apicoplast biogenesis that have so far gone undetected.
One surprising gene we identified was PfAMR1 which encodes a TIM-barrel domain found in diverse enzymes catalyzing small molecule reactions (Nagano et al., 2002) . PfAMR1 may have evolved from gene duplication of indole-3-glycerol phosphate synthase (IGPS), an enzyme in the tryptophan biosynthetic pathway (Jiroutova et al., 2007) . However, the evolutionary pattern of retention in apicomplexan parasites lacking trytophan biosynthesis and loss in Cryptosporidium spp., concomitant with plastid loss, supports a critical function of AMR1 in the apicoplast independent of trytophan biosynthesis. We hypothesize that PfAMR1 may be involved in biosynthesis of a specialized lipid or signaling molecule required specifically for building new plastids in this lineage. Multiple new AMR genes identified in this study provide striking examples of the unexpected findings enabled by unbiased screens.
Uncovering novel apicoplast biogenesis pathways also has important biomedical applications. While targeting the metabolic function of the apicoplast has been a major strategy for antimalarial drug discovery (Jomaa et al., 1999) , it has become apparent that apicoplast biogenesis is equally or likely more valuable as a therapeutic target (Amberg-Johnson et al., 2017) . These distinct pathogen pathways are nonetheless required in every proliferative stage of the Plasmodium lifecycle and conserved among apicomplexan parasites. Targeting apicoplast biogenesis has the benefit of efficacy against multiple Plasmodium life stages and multiple pathogens. Consistent with this broad utility, antibiotics that inhibit translation in the apicoplast and disrupt its biogenesis are used clinically for malaria prophylaxis, acute malaria treatment, and treatment of babesiosis and toxoplasmosis (Dahl and Rosenthal, 2007; Fichera and Roos, 1997; Goodman et al., 2016) .
Until now, a forward genetic screen for essential pathways in blood-stage Plasmodium has not been achieved. Previous screens in murine P. berghei and the human malaria parasite P. falciparum identified non-essential genes required for gametocyte formation (Ikadai et al., 2013; Sinha et al., 2014) , the developmental stage required for mosquito transmission. Functional screens for essential pathways have been impeded by several technical challenges, including the low transfection efficiency of P. falciparum, in vivo growth requirement of P. berghei, and absence of efficient methods for generating conditional mutants in both organisms (de Koning-Ward et al., 2015) . Nonetheless, genome-scale deletion screens in P. berghei and P. falciparum using a homologous recombination-targeted deletion library or saturating transposon-based mutagenesis, respectively, have revealed a plethora of essential genes (Bushell et al., 2017; Zhang et al., 2018) . Functional assignment of these essential genes is a priority. In this context, the apicoplast biogenesis screen presented here is a major milestone towards unbiased functional identification of novel, essential genes.
A top priority for "version 2.0" is to expand the screen to genome scale, maximizing our ability to uncover novel pathways. Apicoplast biogenesis is a complex process encompassing a multitude of functions and is expected to require hundreds of gene products. The identification of 12 candidates genes in the current screen is far from saturating. The most significant bottleneck is the dependence of this screen on chemical mutagenesis. Mapping mutations by whole-genome sequencing limits the number of mutants that can be analyzed and in our study, less than half had a detectable point mutation. Specific mutations identified in candidate genes also need to be validated one-by-one. In this study, four nonsense mutations were validated by conditional knockdown, while a missense mutation in PfFtsH1 was validated using an available activity assay. Although we were able to demonstrate loss-of-function as result of the PfFtsH1 I437S variant, other missense mutations identified in genes of unknown function will be challenging to follow up with available genetic tools. Given these limitations, an alternative mutagenesis method will increase the screen throughput. Options include adaptation of the piggyBac transposon developed for the P. falciparum deletion screen (Zhang et al., 2018) or development of large-scale targeted mutagenesis. Switching to more genetically-tractable apicomplexan organisms, such as P. berghei or Toxoplasma, would provide ready options for large-scale targeted gene disruptions (Bushell et al., 2017; Sidik et al., 2016) . However, these would have to be performed under conditional regulation since chemical rescue of the apicoplast is not feasible in these organisms. We anticipate that continued advances in genetic methods in apicomplexan organisms will open up opportunities to expand this screen in the future. (D) Genomic loci of SNVs identified in coding regions of mutant clones. The mutagenized populations from which each clone was derived is indicated. For specific mutations, see also Table 1 and Table S2 . 
Methods
Parasite culture and transfections P. falciparum Dd2 attB (MRA-843) were obtained from MR4. NF54 Cas9+T7 Polymerase parasites were kindly provided by Jacquin Niles. Parasites were grown in human erythrocytes at 2% hematocrit (Stanford Blood Center) in RPMI 1640 media (Gibco) and supplemented with 0.25% Albumax II (Gibco), 2 g/L sodium bicarbonate, 0.1 mM hypoxanthine (Sigma), 25 mM HEPES, pH 7.4 (Sigma), and 50 µg/L gentamicin (Gold Biotechnology) at 37°C, 5% O2, and 5% CO2.
For transfections, 50 µg of plasmid DNA was added to 200 µL packed red blood cells, adjusted to 50% hematocrit in RPMI 1640, and electroporated as previously described (Deitsch et al., 2001) . On day 4 post-transfection, parasites were selected for with 2.5. mg/L blasticidin S (RPI Research Products). TetR/DOZI strains were cultured with 500 nM anhydrous tetracycline (ATc) for the entire duration of transfection. For TetR/DOZI strains expressing ACPL-GFP or GFP-PfAtg8, parasites were additionally selected for with 500 µg/mL G418 sulfate (Corning) during transfection.
Cloning
Oligonucleotides were purchased from the Stanford Protein and Nucleic Acid facility or IDT. gBlocks were ordered from IDT. Molecular cloning was performed using In-Fusion cloning (Clontech) or Gibson Assembly (NEB). Primer and gBlock sequences for all cloning are available in Table S3 .
To generate the plasmid pRL2-mCherry-T2A-ACPL-GFP, T2A-ACPL-GFP was first amplified from the pRL2-ACPL-GFP vector. mCherry was amplified from pTKO2-mCherry vector (kind gift from J. Boothroyd) and inserted in front of T2A-ACPL-GFP in the pRL2 backbone using the In-Fusion Cloning kit (Takara). To generate the pL2-mCherry-T2A-ACPL-GFP-degron plasmids, T2A-ACPL-GFP-degron was amplified from pRL2-mCherry-T2A-ACPL-GFP.
For CRISPR-Cas9-based editing of endogenous Pf3D7_0518100, Pf3D7_1126100, Pf3D7_1305100 and Pf3D7_1363700 loci, sgRNAs were designed using the eukaryotic CRISPR guide RNA/DNA design tool (http://chopchop.cbu.uib.no/). To generate a linear plasmid for CRISPR-Cas9-based editing, left and right homology regions were first amplified for each gene. For each gene, a gBlock containing the recoded coding sequence C-terminal of the CRISPR cut site and a triple HA tag was synthesized with appropriate overhangs for Gibson Assembly. This fragment along with the left homology region was simultaneously cloned into the FseI/ApaI sites of the linear plasmid pSN054-V5. Next, the appropriate right homology region and a gBlock Table S3 . Primers used in this study. Related to Figures 1, 4-6 , and S1
